NOTCH1 and breast cancer: While Pin1 levels did not affect the clinical outcome in all patients, we found that in grade 3 breast cancer high Pin1 levels correlate with a worse outcome in patients with activated Notch1 signature (high NDT-high PIN1, Fig 9D), but not in patients with low NDT signature expression (supplementary Fig S9E).